TITLE

Senate Bill Seeks Patent Reform

PUB. DATE
April 2011
SOURCE
Pharmaceutical Representative;Apr2011, Vol. 41 Issue 4, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the changes of the patent system due to the approval of the America Invents Act by the U.S. Senate in the U.S.
ACCESSION #
59897134

 

Related Articles

  • Patent medicine, '90s style. Stevenson, Martin M. // Modern Medicine;Jan97, Vol. 65 Issue 1, p2 

    Focuses on legislation that would strip away a physician's right to patent a medical procedure. Issues on the need for incentives to encourage physicians to develop new medical breakthroughs.

  • ...but Sen. Hatch is dissuaded.  // Ophthalmology Times;7/31/95, Vol. 20 Issue 29, p4 

    Reports that industrial pressure has discouraged Senate Judiciary Committee Chairman Orrin Hatch from sponsoring a proposed legislation to prevent the issuance of medical methods patents.

  • Generic Treatment Claims: Do They Hold Water? Valoir, Tamsen // Pharmaceutical Executive;Apr2003, Vol. 23 Issue 4, p60 

    Discusses a legal contention regarding the validity of patented generic treatment claims. Facts of the case; Insufficiency of information in patent claims; Issue on the patenting of the physiological effect of the drug or mechanism of action during drug use.

  • The Positive Side of Negative Disclaimers. Mohr, Judy M.; Freschi, Gina // BioPharm International;Jun2007, Vol. 20 Issue 6, p36 

    The article considers the use of negative disclaimer, an approach for dealing patent application, in the U.S. and European biopharmaceutical and pharmaceutical companies. The European patent system is more lenient and will permit a disclaimer in defined situations compared to the U.S. patent...

  • Patent vs patient rights. Nevin, Tom // African Business;Jun2001, Issue 266, p30 

    Reports the withdrawal of the objection of the Pharmaceutical Manufacturers' Association to the proposed Medicines and Related Substances Control Amendment Act in South Africa. Delay in the implementation of a model for pharmaceutical business; Provisions of the Medicines Act; Introduction of a...

  • Big pharma in South Africa launches IP campaign.  // PharmacoEconomics & Outcomes News;Feb2014, Vol. 696 Issue 1, p1 

    The article reports on protests from pharmaceutical companies against draft patent law reforms in South Africa which would prevent pharmaceutical companies from tweaking formulations of its drugs to extend patents, according to the journal "Lancet."

  • Novartis Fights India Patent Rejection in Court. DAIGLE, KATY // India -- West;9/16/2011, Vol. 36 Issue 43, pA40 

    The article reports on the provision of Patent Act 2005 which allows India to deny patents for drugs for cancer, AIDS, and other illnesses, highlighting the case of the application of Swiss manufacturer Novartis AG for its cancer treatment Gleevec.

  • Prescription drug costs make politicians walk a tightrope. Myers, Dennis // Las Vegas Business Press;04/24/2000, Vol. 17 Issue 16, p5 

    Focuses on the efforts of United States politicians to address the issues of prescription drug costs. Aspects of drug-related legislation filed at the U.S. Congress; Lobbying effort of Schering-Plough to extend the patent on its drug Claritin; Significance of the legislation for senior citizens...

  • Support grows for patents bill...  // Ophthalmology Times;7/31/95, Vol. 20 Issue 29, p4 

    Reports on the support given by lawmakers to a legislation prohibiting the issuance of medical method patents for procedures not connected with devices or drugs. Concerns on the dispute between US Representatives Dana Rohrabacher and Carlos Moorhead.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics